DRKS00007144已完成不适用
Impact of antiplatelet effect of monotherapy with clopidogrel on clinical events in patients on vitamin K-antatonists undergoing coronary stent implantation - ExcelsiorOAC
niversitäts-Herzzentrum Freiburg Bad KrozingenKlinik für Kardiologie und Angiologie II0 个研究点目标入组 100 人开始时间: 2014年11月10日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 Years 至 one（—）
- 性别
- All
入选标准
- •patients undergoing coronary stent implantation with indication for oral anticoagulation for at least 6 months
- •- pretreatment with ASA and clopidogrel
- •- planned treatment with clopidogrel and vitamin K-antagonist following percutaneous coronary intervention
- •- age >=18 years
- •- written informed consent
排除标准
- •- high-risk acute coronary syndrome (because usually treated with triple therapy)
- •- fibrinolysis or GP IIb/IIIa antagonist with 5 days before enrollment
- •- contraindication for clopidogrel or vitamin K-antagonist
- •-thrombopenia
- •- known severe coagulopathy
- •- severe disease leading to a life expectancy of less than 1 year
研究者
相似试验
进行中（未招募）
1 期
Single versus Dual Antiplatelet Therapy in patients with Incomplete Revascularization after Coronary artery bypass graft surgeryEUCTR2017-001754-33-ITIVERSITÀ CAMPUS BIO-MEDICO DI ROMA800
已完成
不适用
Impact of 1-month Dual Antiplatelet Therapy After Treatment with Drug-Coated Balloon for Femoropopliteal Artery DiseaseArteriosclerosis obliteransJPRN-UMIN000034867Hyogo College of Medicine151
终止
不适用
Comparison of the effect of an anti-platelet intervention with Ticagrelor versus placebo on participants with asymptomatic elevations in troponin TACTRN12614000189628Professor Derek Chew420
已完成
4 期
The efficacy and safety of the antiplatelet therapy in acute non-cardiogenic ischemic stroke.on-cardiogenic ischemic stroke in acute phase.JPRN-UMIN000006931Department of Neurosurgery, Faculty of Medicine, University of Tsukuba130
进行中（未招募）
1 期
Evaluation of antiplatelet effects of different dosages of aspirin in type 2 diabetic patients.Patients with type 2 diabetes mellitus with an indication for aspirin treatment or already on aspirin treatment.EUCTR2007-003186-40-SEKarolinska Institute30